Early use of monoclonal antibodies may reduce hospitalizations, deaths



[ad_1]

People with COVID-19 can reduce their risk of hospitalization and death by up to 85% if they receive monoclonal antibody treatments in the early stages of their illness, Dr Anthony Fauci said Tuesday.

The White House chief medical adviser has said that administering lab-made antibodies to fight the virus before a patient is hospitalized can prevent serious illness risks by 70 to 85 percent.

“It is important to stress that this must be done at the onset of the infection and not, of course, wait until a person is sick enough to be hospitalized,” Fauci said during a COVID-19 press briefing .

“This is when you get the best effect. And again, being an underutilized intervention, we want people, including doctors as well as potential patients, to realize the benefit of this very effective way of treating infection early. “

Dr.Anthony Fauci testifies before the Senate Committee on Health, Education, Work and Pensions, on Capitol Hill in Washington, Tuesday, July 20, 2021.
Dr Fauci said giving monoclonal antibody treatments can reduce a patient’s risk of serious illness by 70-85%.
AP Photo / J. Scott Applewhite, Pool

Fauci said the treatment could significantly benefit certain risk groups, such as people over 65, pregnant women, and people with weakened immune systems.

“Ultimately, this is a very effective intervention for COVID-19. It is underused and we strongly recommend that you use it to the fullest, ”Fauci said.

[ad_2]

Source link